We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toMapping-the-Patient-and-Site-Experinece-During-a-Clinical-Trial

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

The Adventures of Patient Experience in Drug Development

    Session Chair(s)
      Abby  Jeske, PharmD

      Abby Jeske, PharmD

      • Clinical Project Manager
      • Eli Lilly and Company, United States
    Sponsors constantly brainstorm ways to become more customer centric. This session presents an overview of the clinical trial experience methods created to capture and improve the experiences of patients and sites in clinical studies.
    Learning Objective : Identify areas of importance and specific pain points for patients and site personnel within the experience maps; Describe ways in which clinical trial teams can use the knowledge from the maps and other examples to make future clinical trials more customer centric; Discuss what project/program managers can do to enable trial designs that improve site, investigator, and patient experiences.
      Abby  Jeske, PharmD

      Mapping the Patient and Site Experience During a Clinical Trial

      Abby Jeske, PharmD

      • Clinical Project Manager
      • Eli Lilly and Company, United States
      Tanja  Keiper, DrSc

      How Patient Advisory Boards Can Help Teams Elicit Feedback

      Tanja Keiper, DrSc

      • Director, GCO External Innovation
      • Merck KGaA, Germany
      T.J.  Sharpe, PMP

      Patient Perspective

      T.J. Sharpe, PMP

      • Patient Advocate
      • Starfish Harbor LLC , United States